Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Heather Polizzi"'
Autor:
Ronald Hoffman, Kelly M. Shaffer, Marina Kremyanskaya, Daniel C. McFarland, Jimmie C. Holland, John Mascarenhas, Heather Polizzi
Publikováno v:
Psychosomatics. 59:472-480
Background The physical symptom burden of patients with myeloproliferative neoplasms (MPNs) may last for extended periods during their disease trajectories and lead to psychologic distress, anxiety, or depression or all of these. Objective This study
Autor:
John Mascarenhas, Daniel C. McFarland, Jimmie C. Holland, Heather Polizzi, Marina Kremyanskaya, Ronald Hoffman, Kelly M. Shaffer
Publikováno v:
Journal of the National Comprehensive Cancer Network. 15:1503-1508
Background: Patients with myeloproliferative neoplasms (MPNs) can have a severe physical symptom burden over an extended disease trajectory that contributes to decreased quality of life. Few studies, however, have characterized which patients most fr
Autor:
John Mascarenhas, Marina Kremyanskaya, Heather Polizzi, Ronald Hoffman, Jimmie C. Holland, Daniel C. McFarland
Publikováno v:
Journal of the National Comprehensive Cancer Network. 14:1563-1570
BCR-ABL-negative myeloproliferative neoplasms (MPNs) represent a heterogeneous group of diseases, including essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF). Psychological manifestations among these diseases have not bee
Autor:
John Mascarenhas, Megan Johnson Shen, Marina Kremyanskaya, Daniel C. McFarland, Jimmie C. Holland, Heather Polizzi, Ronald Hoffman
Publikováno v:
Psychosomatics. 58(1)
Myeloproliferative neoplasms (MPNs), a group of chronic hematologic malignancies, carry significant physical and psychological symptom burdens that significantly affect patients' quality of life.We sought to identify the relationship between early ch
Autor:
John Mascarenhas, Megan Johnson Shen, Jimmie C. Holland, Ronald Hoffman, Marina Kremyanskaya, Heather Polizzi, Daniel C. McFarland
Publikováno v:
Psychosomatics. 58(1)
Patients with chronic hematologic malignancies such as myeloproliferative neoplasms suffer from significant physical and psychological symptom burden. This study examined their willingness to accept an antidepressant and their preferences for which p